MissionIR Articles
-
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Expands Focus with Development of New NanoAb Therapeutics
Last September, a joint steering committee comprising professionals from BiondVax Pharmaceuticals (NASDAQ: BVXV), the Max Planck Institute for Multidisciplinary Sciences (“MPG”), and the University Medical Center Göttingen (“UMG”), made a decision. Established to guide the…
-
MissionIRNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Announces 2023 PEA Results on Los Azules Copper Project
McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) today provided results of the updated Preliminary Economic Assessment (the “2023 PEA”) on the Los Azules Copper Project in San Juan Argentina (the “project”). The project is 100%…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces Upcoming Robot Roadshow in West Texas
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, is releasing the next landing destination for its popular Robot Roadshow. The company announced that the engaging, in-person…
-
Genprex Inc. (NASDAQ: GNPX) CMO Video Discusses Advances in Company’s Fight Against Tumors
Clinical-stage gene therapy developer Genprex (NASDAQ: GNPX) is expanding the breadth of its drug candidate potential with positive results from a preclinical study that examines the anti-tumor immune response of a gene believed to play…
-
Freight Technologies Inc. (NASDAQ: FRGT) Shares anticipated 0-200% Revenue Growth for 2023; Reports Highest Monthly Increase in New Clients during month of March
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company on a mission to revolutionize cross-border shipping by offering carriers increased growth opportunities and shippers with flexibility, visibility, and simplicity, is working hard to have its best…
-
MissionIRNewsBreaks – Genprex Inc.’s (NASDAQ: GNPX) Flagship Candidate Could Potentially Reshape NSCLC Landscape
Genprex (NASDAQ: GNPX) is conducting its Phase 1/2 Acclaim-1 clinical trial evaluating the safety and efficacy of combining REQORSA(R), the company’s innovative drug candidate, in combination with Tagrisso(R) in patients with advanced EGFR mutant non-small…
-
MissionIRNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Committed to Supporting Fintech, Digital Money Processes in Underserved Markets
Fintech Ecosystem Development Corp. (NASDAQ: FEXD) continues to move forward with plans to offer a diverse portfolio of fintech-related products and services for consumers and businesses throughout the global financial ecosystem. “Digital money is replacing…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on Promising Results from Diabetes Animal Study
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is releasing additional findings from its DIAB-A22-1 study, a diabetes animal study designed to evaluate the company’s proprietary DehydraTECH-CBD. DehydraTECH is a patented drug-delivery formulation…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Corrects Shareholder Letter to Reflect $0.38 Per Share
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released a letter to its shareholders designed to address the decrease in the company’s share price. The letter noted that earlier this week, the…
-
MissionIRNewsBreaks – CISO Global Inc. (NASDAQ: CISO) Featured in Equity Research Report
CISO Global (NASDAQ: CISO), an industry leading cybersecurity and compliance provider, was featured in a recent equity research report published by Cantor Fitzgerald. The report, titled “Consistent 1Q23 Execution Adjusting for Non-Cash Related Charges/Noise,” adjusts…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 ‘Patrol Bot’ to Boost Security Operations at Traverse Point
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, announced that Traverse Point Condominiums in Henderson, Nevada, signed a contract for its K5 Autonomous Security Robot (“ASR”) subscription…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Shareholder Letter Featuring Status Update
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has issued a shareholder letter providing a business update and responding to questions regarding the company’s share price, which has declined significantly since March 31,…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in Upcoming Maxim Group Virtual Healthcare Conference
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured in an upcoming webcast fireside chat.…
-
D-Wave Quantum Inc. (NYSE: QBTS) and Interpublic Group (NYSE: IPG) Announce Partnership to Use Quantum Computing Applications for Innovation in Marketing Investments and Strategies
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services focused on delivering customer value via practical quantum computing solutions, recently announced a partnership with one of the world’s leading global advertising…
-
Lexaria Bioscience Corp.’s (NASDAQ: LEXX) May Announcements Show Resolve to Continue Supporting R&D ‘Lifeblood’
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, held its 2023 Annual Meeting on the 9th of May, with shareholders voting on several agenda items, including the election of directors, appointment of…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) to Deploy Robots to Join Downtown LA Security Team
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has secured a new contract for one K5 and two K1 Autonomous Security Robots (“ASRs”) from a 50-year real…
-
Genprex Inc. (NASDAQ: GNPX) Announces Positive Data From Phase 1 Clinical Trial Evaluating REQORSA(R) Immunogene Therapy for Late-Stage Non-Small Cell Lung Cancer
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, recently announced that positive data from the Phase 1 portion of its Acclaim-1 clinical trial evaluating…
-
Electronic Servitor Publication Network Inc. (XESP) Transforms B2B Companies with “Growth as a Service”
The digital landscape has transformed and evolved over the past few years – going from a focus primarily on SEO, to social media, content, and video marketing campaigns. Now, there are thousands of tactics being…
-
MissionIRNewsBreaks – CISO Global Inc. (NASDAQ: CISO) Expected to Build on Growth Momentum with Larger Enterprise Contracts, ‘Highly Favorable’ Landscape
CISO Global Inc. (NASDAQ: CISO), a leading provider of global cybersecurity and compliance, was featured in a recent Cantor Fitzgerald equity research report. “Noting that the company is strategically positioned to fill the cybersecurity talent…
Search Articles
Latest Articles
- FAVO Capital Inc. (FAVO): When Private Credit Meets Real Estate Collateralization
- AI and the Copper Conundrum: How Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Fits into the Supply Equation
- Silvercorp Metals Inc. (NYSE-A/TSX: SVM) El Domo Environmental License Upheld as Ecuador’s Constitutional Court Dismisses Final Challenge
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
- MissionIRNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $6.9 Million Public Offering Including Full Over-Allotment Option